Validation of a Clinicopathological and Gene Expression Profile (CP-GEP) model for sentinel lymph node metastasis in primary cutaneous melanoma.

CONCLUSIONS: The CP-GEP model is a non-invasive and validated tool that accurately identified patients with primary cutaneous melanoma at low risk for nodal metastasis. In this validation cohort, the CP-GEP model has shown potential to reduce SLNB procedures in melanoma patients.
PMID: 32844403 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - August 25, 2020 Category: Dermatology Authors: Mulder EEAP, Dwarkasing JT, Tempel D, van A, der Spek, Bosman L, Verver D, Mooyaart AL, van AAM, der Veldt, Verhoef C, Nijsten TEC, Grunhagen DJ, Hollestein LM Tags: Br J Dermatol Source Type: research